All Categories
Cost-effectiveness of an artificial intelligence predictive model for guiding...
The ArteraAI Prostate Test (ArteraAI Inc.) is the first predictive biomarker for benefit of adding short-term androgen depriv [...]
Validation of Multimodal and Image-Only Artificial Intelligence Digital Pathology–Based...
Accurate risk stratification is essential to personalizing treatment decision-making in prostate cancer, enabling escalation [...]
Reimagining Cancer Care: The Role of Artificial Intelligence in...
Eliezer Van Allen discusses his keynote address on artificial intelligence in cancer care, describing the transition from sta [...]
March 2026 Webinar
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating prostate cancer. For lower-risk pat [...]
OpenAI, Anthropic Shake Up Digital-Health Sector With Their Own...
The arrival of OpenAI and Anthropic in healthcare promises to jolt the sector, threatening some startups as it creates opport [...]
5 ways AI could save cancer patients money
For patients, the price of cancer testing and treatment can add more stress to an already difficult journey. As AI begins to [...]
Did my prostate cancer screening do more harm than...
In 2002, at age 55, I underwent my first digital rectal exam. The routine check set me on a 15-year path that transformed me [...]
Can Digital Pathology Improve Risk Stratification After Prostatectomy?
A study published in European Urology describes the development and validation of a multimodal artificial intelligence (AI)–d [...]